Switching patterns among patients with AOM tirzepatide Between January and April, 99.4% of patients with an active supply of AOM tirzepatide in a given month had an active supply of AOM tirzepatide in the subsequent month, showing strong persistence with very limited switching
Before your appointment , it is helpful to maintain a brief record of your weight measurements (ideally taken at the same time of day, using the same scales), dietary patterns, physical activity levels, and any new symptoms
The 9mg dose evaluated in GLORY-2 represents the highest dose studied in Phase 3 trials
Ozempic contains semaglutide, a GLP-1 receptor agonist
PMID: 21443845 [13] Sumitra M, Manikandan P, Gayathri VS, Mahendran P, Suguna L